Skip to main content
OpenTrials
Completed

NCT Number: NCT01708733

The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver Function

The aim of the study is to examine whether the Chinese herbal formula (KSY) is effective on HCV Carrier With Abnormal Liver Function.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Function

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Taipei City Hospital

Taipei, Taiwan, 886

About this study

percentage of change on HCV RNA titer and liver function (GPT).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 40 < GPT <200 HCV carrier Age: 18-65 yrs old

Exclusion criteria

  • Creatinine >2.0 mg/dL Total bilirubin > 2.0mg/dL Not suitable patients diagnosis by physician in charge.

Treatment and study plan

KSY

Drug

Chinese herbal formula

Primary outcomes

  1. HCV RNA titer

    Time frame: 6 weeks

Secondary outcomes

  1. Serum GPT level

    Time frame: 6 weeks

Other outcomes

  1. WHOQOL-BREF

    Time frame: 6 weeks

Sponsors and collaborators

Lead sponsor

Taipei City Hospital

Other Gov

Registry information

Official study title

An Evaluation of the Extract of KUAN SIN YIN on Hepatitis C: a Randomized, Double-blinded and Placebo-controlled Clinical Trial.

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Oct 17, 2012
Registry last updated
May 29, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.